238 related articles for article (PubMed ID: 21190443)
21. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
23. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
25. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
[TBL] [Abstract][Full Text] [Related]
26. Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.
Nishihara E; Chen CR; Higashiyama T; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
Thyroid; 2010 Nov; 20(11):1307-14. PubMed ID: 20929407
[TBL] [Abstract][Full Text] [Related]
27. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
[TBL] [Abstract][Full Text] [Related]
28. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
29. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.
Trülzsch B; Krohn K; Wonerow P; Chey S; Holzapfel HP; Ackermann F; Führer D; Paschke R
J Mol Med (Berl); 2001; 78(12):684-91. PubMed ID: 11434721
[TBL] [Abstract][Full Text] [Related]
30. Constitutive activities in the thyrotropin receptor: regulation and significance.
Kleinau G; Biebermann H
Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
[TBL] [Abstract][Full Text] [Related]
31. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
32. Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.
Roberts SA; Moon JE; Dauber A; Smith JR
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):343-347. PubMed ID: 28195550
[TBL] [Abstract][Full Text] [Related]
33. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism.
Biebermann H; Schöneberg T; Hess C; Germak J; Gudermann T; Grüters A
J Clin Endocrinol Metab; 2001 Sep; 86(9):4429-33. PubMed ID: 11549687
[TBL] [Abstract][Full Text] [Related]
34. [Disorders caused by mutations of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 1998 Jul; 56(7):1856-60. PubMed ID: 9702065
[TBL] [Abstract][Full Text] [Related]
35. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
[TBL] [Abstract][Full Text] [Related]
36. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
[TBL] [Abstract][Full Text] [Related]
37. A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism.
Nishihara E; Nagayama Y; Amino N; Hishinuma A; Takano T; Yoshida H; Kubota S; Fukata S; Kuma K; Miyauchi A
Endocr J; 2007 Dec; 54(6):927-34. PubMed ID: 18025759
[TBL] [Abstract][Full Text] [Related]
38. A family with a novel TSH receptor activating germline mutation (p.Ala485Val).
Akcurin S; Turkkahraman D; Tysoe C; Ellard S; De Leener A; Vassart G; Costagliola S
Eur J Pediatr; 2008 Nov; 167(11):1231-7. PubMed ID: 18175146
[TBL] [Abstract][Full Text] [Related]
39. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism.
Nwosu BU; Gourgiotis L; Gershengorn MC; Neumann S
Thyroid; 2006 May; 16(5):505-12. PubMed ID: 16756474
[TBL] [Abstract][Full Text] [Related]
40. Expression of beta-arrestins in toxic and cold thyroid nodules.
Voigt C; Holzapfel H; Paschke R
FEBS Lett; 2000 Dec; 486(3):208-12. PubMed ID: 11119705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
